Company: Dr. Reddy's Laboratories Ltd. Category: Company News

BS ReporterHyderabad, 26 July: Dr Reddy's Laboratories Limited announced today that it has launched Hervycta (Trastuzumab), a biosimilar of Roche's Herceptin in India, indicated for the treatment of certain cancers.Commenting on the launch, M V Ramana, CEO-Branded Markets at Dr Reddy's said,"We strive every day to do what matters most for patients. Hervycta is a step forward in our effort to accelerate acess to cancer patients in India, in the oncology biosimilar space."Herceptin and its biosimilars had India sales of approximately Rs 2.90 billion for the most recent twelve months ending in December 2017, according to the company."The launch of Hervycta will immensely benefit women in India who are suffering from HER2-positive breast cancer and are in need of access to high quality, affordable innovative medicines," Raymond De Vre, senior vice president and head, Boilogics at Dr Reddy's said.---ends
July 26, 2018, 12:20 p.m.

With sales of around $1.86 billion annually, Suboxone was one of the key near-term launches lined up by Dr Reddy's this year
July 14, 2018, 4:02 p.m.

Dr Reddy’s Laboratories Ltd will appeal the decision made by the US District Court for the District of New Jersey in a preliminary injunction hearin
July 14, 2018, 2:13 p.m.

The tablets are available in 200 mg in the bottle count sizes of 100 and 500
July 11, 2018, 1:05 p.m.

Briviact is approved as an adjunctive therapy for the treatment of partial-onset seizures in epilepsy patients who are 16 years of age and older
July 9, 2018, 6:37 p.m.

Pharma major Dr Reddy’s Laboratories Ltd has launched Repatha (evolocumab) the first and only PCSK9 Inhibitor available in India as approved by the
July 2, 2018, 10:26 p.m.

These recalled tablets are in the strengths of 10 mg, 20 mg and 40 mg
July 1, 2018, 1:56 p.m.

Indivior Plc got a breather on Friday as a US court extended a restraining order blocking a rival from launching a generic version of its best-selli
June 29, 2018, 3:32 p.m.

The drug has been approved by the US Food and Drug Administration
June 19, 2018, 4:15 p.m.

Pharma major Dr Reddy's Laboratories Ltd has launched Levetiracetram in Sodium Chloride Injection in the US market.The product is a therapeutic equiv
June 19, 2018, 1:40 p.m.